Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-04-08A Clinical Trial of Nitrous Oxide for Treatment-Resistant Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2021-04-08Augmenting Repetitive Transcranial Magnetic Stimulation (rTMS) With Cognitive Control Training in Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2021-04-01Ketamine IV Classic Protocol : Five Years Follow up Clinical Evaluation.
-
CLINICAL_TRIALS study record update · 2021-03-30Efficacy of Supported Employment Within the OIF/OEF Patient Aligned Care Team
-
CLINICAL_TRIALS study record update · 2021-03-18Combined Wake Therapy, Light Therapy, and Lithium for Bipolar and Refractory Depression
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-03-16Seasonal Affective Disorder: Exploratory Investigation of Seasonal Variations in Brain Structure and Connectivity as a Predictor for Depressive Severity
-
CLINICAL_TRIALS study record update · 2021-03-15A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2021-02-23McLean and Genomind Prospective Study of Pharmacogenetic Testing
-
CLINICAL_TRIALS study record update · 2021-02-18Clinical Trial on Efficacy of Repeated Transcranial Magnetic Stimulation (rTMS) to Improve Electroconvulsive Therapy (ECT) in Treatment-Resistant Depression (TRD): STIMAGNECT Study
-
CLINICAL_TRIALS study record update · 2021-02-12Biomarkers of Response to Treatment With Frontal Cortex Stimulation for Anxious Depression
-
CLINICAL_TRIALS study record update · 2021-02-11Neurostimulation & Depression Study
-
CLINICAL_TRIALS study record update · 2021-02-11Investigating the Efficacy of a Top-Down Approach to Cognitive Remediation in Individuals With Affective Disorders
-
CLINICAL_TRIALS study record update · 2021-02-09KOREAN POST MARKETING SURVEILLANCE TO OBSERVE EFFECTIVENESS AND SAFETY OF PRISTIQ (REGISTERED) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER.
-
CLINICAL_TRIALS study record update · 2021-02-01Feasibility and Acceptability of a Healthy Nordic Diet Intervention for the Treatment of Depression: a Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2021-01-29A Randomized, Double-blind, Double-dummy, Controlled Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide - a Pilot Study
-
CLINICAL_TRIALS study record update · 2021-01-22The Role of HNKs in the Antidepressant Effect of Ketamine
-
CLINICAL_TRIALS study record update · 2021-01-15Music Therapy and Dialysis: A Pilot Investigation Into the Effectiveness of Patient-Selected Music Interventions on Physiological, Psychological, and Quality-of-Life Outcomes
-
CLINICAL_TRIALS study record update · 2021-01-13Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
-
CLINICAL_TRIALS study record update · 2021-01-12Investigating Predictors of Treatment Response in Treatment-Resistant Depression (TRD) With Interleaved TMS/fMRI
-
CLINICAL_TRIALS study record update · 2020-12-29A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-12-24A 52-week, Multi-center, Open-label Study of the Safety and Tolerability of Agomelatine Sublingual Tablets in Patients With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2020-12-24A 8-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of Agomelatine 0.5 mg and 1 mg Sublingual Tablets Administered Once Daily in Patients With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2020-12-23Brainsway Deep TMS System for Treatment of Major Depressive Disorder (MDD) Using Intermittent Theta Burst Stimulation (iTBS) Protocol
-
CLINICAL_TRIALS study record update · 2020-12-23An 8-week, Randomized, Double-blind, Fixed Dosage, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy, Safety and Tolerability of Agomelatine 25 mg and 50 mg in the Treatment of Major Depressive Disorder (MDD) Followed by a 52-week, Open-label Extension (CAGO178A2301E)
-
CLINICAL_TRIALS study record update · 2020-12-23A 52-week, Randomized, Double-blind, Placebo-controlled, Multi-center, Parallel-group Study of the Long-term Efficacy, Tolerability and Safety of Agomelatine 25 and 50 mg in the Prevention of Relapse of Major Depressive Disorder (MDD) Following Open-label Treatment of 16-24 Weeks